pharmaceutical industry Archives - Page 2 of 2

Brand-Name vs. Generic Drugs: Are Indian Generics Just as Effective?

Brian RogersJune 2, 20240154 views

The pharmaceutical industry offers a wide range of medications, including high-cost brand-name drugs and more affordable generics. This report analyzes the equivalency in efficacy between Indian WHO-certified generic drugs and their branded counterparts, highlighting differences in inactive ingredients and the economic impact on healthcare. Despite misconceptions, generics contain the same active ingredients and adhere to international quality standards, offering a cost-effective alternative without compromising safety. The lower cost of Indian generics makes essential medications more accessible, particularly in low- and middle-income countries, driving down healthcare costs and expanding access to necessary treatments.

Undermining the Foundations: How Big Pharma and U.S. Politicians Contradict American Ideals

Brian RogersMay 29, 20240182 views

In the U.S., the foundational principles of freedom, equality, and the pursuit of happiness are undermined by the collusion between big pharma, congressional elites, and government agencies. This alliance prioritizes profit over patient welfare, restricting access to affordable medications and violating constitutional promises of life and liberty. To realign with American ideals, there must be reforms to limit pharmaceutical influence, promote competition, and prioritize patient-centric policies. It’s crucial to advocate for a healthcare system that truly serves its people and reflects the nation’s founding values.

Transparency vs. Secrecy: Ashvin Medicara and LegitScript in the Spotlight

Brian RogersMarch 10, 20240336 views

Ordering medications online from international sources has become popular for those seeking affordable pharmaceuticals, but it comes with challenges, notably the risk of customs seizures. This article explores common reasons for package seizures, such as exceeding allowable quantities and including controlled substances, and provides guidance on mitigating these risks. Understanding and navigating these complexities can help individuals manage their healthcare needs legally and safely, ensuring access to necessary medications.